Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Timber Pharmaceuticals (TMBR)

Timber Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:TMBR
DateTimeSourceHeadlineSymbolCompany
28/11/202322:21GlobeNewswire Inc.Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
18/09/202321:05GlobeNewswire Inc.Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing ComplianceAMEX:TMBRTimber Pharmaceuticals Inc
21/08/202313:00GlobeNewswire Inc.Timber Pharmaceuticals to be Acquired by LEO PharmaAMEX:TMBRTimber Pharmaceuticals Inc
03/07/202321:05GlobeNewswire Inc.Timber Pharmaceuticals Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
20/06/202313:00GlobeNewswire Inc.Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
05/06/202313:00GlobeNewswire Inc.Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001AMEX:TMBRTimber Pharmaceuticals Inc
15/05/202321:15GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
31/03/202321:28GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
20/03/202312:00GlobeNewswire Inc.Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental DermatologyAMEX:TMBRTimber Pharmaceuticals Inc
24/02/202313:00GlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
14/12/202213:30GlobeNewswire Inc.Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward OutlookAMEX:TMBRTimber Pharmaceuticals Inc
09/12/202221:05GlobeNewswire Inc.Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAMEX:TMBRTimber Pharmaceuticals Inc
14/11/202213:00GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
09/11/202213:20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
08/11/202221:38Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
08/11/202217:09GlobeNewswire Inc.Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock SplitAMEX:TMBRTimber Pharmaceuticals Inc
03/11/202212:42Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
03/11/202212:22GlobeNewswire Inc.Timber Pharmaceuticals Announces Halt of Common Stock Trading  AMEX:TMBRTimber Pharmaceuticals Inc
26/10/202213:40TipRanksAnalysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), Timber Pharmaceuticals (TMBR)AMEX:TMBRTimber Pharmaceuticals Inc
25/10/202213:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
25/10/202213:00GlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
03/10/202221:16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
03/10/202215:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:TMBRTimber Pharmaceuticals Inc
03/10/202214:00GlobeNewswire Inc.Timber Pharmaceuticals Announces $1.3 Million Registered Direct OfferingAMEX:TMBRTimber Pharmaceuticals Inc
14/09/202213:00GlobeNewswire Inc.Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
12/09/202221:43Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
02/09/202221:17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
29/08/202221:17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
29/08/202221:05GlobeNewswire Inc.Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing DeficiencyAMEX:TMBRTimber Pharmaceuticals Inc
29/08/202213:00GlobeNewswire Inc.Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV CongressAMEX:TMBRTimber Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:TMBR